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On behalf of all focus group participantsPurpose of review
There is an urgent need to discuss the uncertainties and paradoxes in clinical decision-making after severe
traumatic brain injury (s-TBI). This could improve transparency, reduce variability of practice and enhance
shared decision-making with proxies.
Recent findings
Clinical decision-making on initiation, continuation and discontinuation of medical treatment may
encompass substantial consequences as well as lead to presumed patient benefits. Such decisions,
unfortunately, often lack transparency and may be controversial in nature. The very process of decision-
making is frequently characterized by both a lack of objective criteria and the absence of validated
prognostic models that could predict relevant outcome measures, such as long-term quality and satisfaction
with life. In practice, while treatment-limiting decisions are often made in patients during the acute phase
immediately after s-TBI, other such severely injured TBI patients have been managed with continued
aggressive medical care, and surgical or other procedural interventions have been undertaken in the
context of pursuing a more favorable patient outcome. Given this spectrum of care offered to identical
patient cohorts, there is clearly a need to identify and decrease existing selectivity, and better ascertain the
objective criteria helpful towards more consistent decision-making and thereby reduce the impact of
subjective valuations of predicted patient outcome.
Summary
Recent efforts by multiple medical groups have contributed to reduce uncertainty and to improve care and
outcome along the entire chain of care. Although an unlimited endeavor for sustaining life seems
unrealistic, treatment-limiting decisions should not deprive patients of a chance on achieving an outcome
they would have considered acceptable.
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Many patients who sustain severe traumatic brain








ing (surgical) interventions may result in survival,
but there is neither a common opinion on how
to define an unfavorable outcome, nor on the
time horizon of assessing such outcome [5–8,9
&
].
Treatment-limiting decisions likely result in clinical
deterioration and death [10,11,12
&&
]. Most acute
treatment decisions are poorly supported by high-
quality evidence and prognostic algorithms, leaving





haps in light of such lack of clarity, nonadherence
to guidelines and substantial treatment variation
remains pervasive [16,17,18
&
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doxes by reviewing the literature and reporting
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KEY POINTS
 Although multiple recent efforts have contributed to
reduce uncertainty and to improve care and outcome
for severe traumatic brain injury (s-TBI) patients
along the entire chain of care, there remain many
uncertainties and paradoxes and a lack of objective
criteria in clinical decision-making after s-TBI.
 Although important for decision-making, well validated
prognostic models predicting long-term outcome on
quality of life and satisfaction with life after s-TBI are
currently unavailable.
 Some of the most severely injured TBI patients have
been reported to have achieved ‘favorable’ outcome
and (surgical) interventions are generally considered
beneficial for patient outcome.
 To further improve s-TBI care, future research should
identify and decrease the existing selectivity and
identify objective criteria in decision-making and
reduce the impact of subjective valuations of predicted
patient outcome.
Cardiopulmonary resuscitation and other emergencies
Copfocused on clinical decision-making in initiating or
withholding (surgical) intervention to patients after
s-TBI. This position paper was written following a
series of discussions with an expert panel of profes-
sionals from different backgrounds, and should
serve as a starting point for further discussions rather
than constitute a final outcome process.PROFESSIONAL CODE OF PHYSICIANS
Physicians practice medicine by working according
to several codes of conduct and by following four
universally accepted moral principles in medical
ethics (Table 1) [19–23].
Autonomy of the patient is inherently compro-
mised in patients with s-TBI, and proxies are often
absent during the acute phase, improperly desig-





]. Physicians then are
responsible for selecting a strategy they consider in
line with a patients’ best interests, that is, beneficence.
However, both medical and surgical or proceduralTable 1. Moral principles in medical ethics
Principle Description
Autonomy A norm of respecting and supporting autonom
Beneficence A group of norms pertaining to relieving, less
benefits against risks and costs.
Nonmaleficence A norm of avoiding the causation of harm.
Justice A group of norms for fairly distributing benefi
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yright © 2019 Wolters Kluwer Health, Inc. Unauthinterventions carry risks of inducing harm, creating a
difficult equilibrium between beneficence and non-
maleficence [2,9
&
,27,28]. Lastly, justice requires the
fair distribution of benefits, risks and limited medical
goods and services. As such, resources should
ethically be restricted when used on so-called inef-
fective and disproportional treatment efforts, as it
will deprive other patients of potentially effective
treatments.TREATMENT-LIMITING DECISIONS
Treatment-limiting decisions, including withhold-
ing lifesaving (surgical) interventions or withdrawal
of life-sustaining medical treatment, are sometimes
made within the first 2 days after s-TBI, allowing for,
and leading to consequences of death, further dete-





]. Furthermore, defining recovery is
relative, as it may encompass the entire spectrum
from saving a patients’ life, achieving good health-










Although withdrawal of life-sustaining mea-
sures can be morally justified, and in line with
patients’ and proxies’ preferences and values, it
should be noted that such decisions are typically
based on nondate-driven clinical prognostication,
the goal of achieving survival with an imprecisely
defined ‘favorable’ outcome [33
&&
]. As ‘favorable’
outcome has been reported in even some of the
most severely injured patients, treatment-limiting
decisions in patients that might have achieved
‘favorable outcome’ must, therefore, arguably be





Several recent studies have aimed to identify what
specific reasons or values constitute decision-
making in severe brain injuries by medical teams,







,35,36]. Physicians are likely toous decisions.
ening, or preventing harm and providing benefits and balancing
ts, risks, and costs.
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Table 2. Reasons, including potential outcome perspectives, to strongly consider treatment-limiting decisions
Number Proposed reasons
1 Brain death, from a patient perspective (not considering interests regarding organ donation procedures) [38,39]
2 (chronic) Unresponsive wakefulness syndrome [40&&,41&&]
3 Minimally conscious state – (minus) (i.e. visual pursuit, localization of noxious stimuli, appropriate smiling or crying
to emotional stimuli) [40&&,42]
4 An available, unquestionable, written and signed specific advance directive of the patient that prohibits treatment in
a specific situation (possibly related to expected outcome)
5 A proxy opinion that is unquestionably based on patient preferences and that is not in conflict with the attending
medical teams’ considerations, that prohibits treatment in a specific situation (possibly related to expected
outcome)
6 A patient’s view (or when necessary a reconstructed vision through surrogates) on life and quality of life is contrary
to the outcome that can be expected from the best available prognostic models.
7 Treatment costs along the whole chain of care that are not cost-effective and higher than the maximum amount that
has been decided by national legislation
Reasons are reported in random order.
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include their personal valuation of predicted patient
outcome in their treatment considerations based
on a mix of factors, such as religious background,
personal and clinical experience, culture, national
legislation, and even the socioeconomic status of
the patient [18
&
,37]. This introduces the risk of
selectivity and is not evidence-based medicine [18
&
].
To elaborate on this, the authors, specialists in
neurosurgery, intensive care medicine, rehabilita-
tion, chronic care, anthropology and medical ethics,
executed a multiple occasion professionally led
focus group discussion. We explored and described
the process and reasoning of decision-making in this
manuscript and propose several reasons that would
legitimize treatment-limiting decisions (Table 2).‘ACCEPTABLE’ VERSUS ‘UNACCEPTABLE’
OUTCOME
Valuation of outcome is probably one of the most
important aspects in decision-making, but exact
definitions of acceptable or unacceptable outcome
after s-TBI remain elusive [18
&
,43]. In literature,
‘upper severe disability’ (Glasgow Outcome Scale-
Extended) and ‘the inability to walk’ or ‘functionally
dependent’ (Modified Rankin Scale of 4) are some-
times considered favorable outcomes, whereas most
physicians and researchers would classify this out-
come degree as unfavorable [43,44]. Most compe-
tent individuals, irrespective of age, religion or
background, consider survival with unfavorable
outcome on the Glasgow Outcome Scale (GOS)
unacceptable. However, survivors with so-called
‘unfavorable outcome’ after decompressive craniec-
tomy for s-TBI and caregivers of patients after
decompressive craniectomy appear to change their
definition of ‘a good quality of life’ (QOL) and would1070-5295 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese





]. Clearly, the favorable/unfavorable
cut-off point used in prognostic models and TBI
studies does not necessarily represent an accept-
able/unacceptable outcome for patients [9
&
,43].
Healthy individuals are generally unable to pre-
dict accurately what future QOL would be acceptable
or unacceptable to them, because they often underes-
timate their ability to adapt to levels of disability they
previously considered unacceptable [45]. The absence
of a linear connection between disabilities and expe-
rienced QOL known as the disability paradox is seen in
patients with severe disabilities reporting a good QOL
(i.e. s-TBI, locked-in syndrome, Duchenne) [9
&
,46,47].
This does not validate lifesaving/sustaining interven-
tions in all patients, but suggests that physicians
should acknowledge that an unacceptable outcome
in their opinion may not necessarily be unacceptable
to patients.
Determining cut-off points of acceptability is
highly arbitrary and nearly impossible because of
countless outcome possibilities and substantial var-
iation in peoples’ ever-changing desires and inter-
pretations of a ‘good life’. For instance, a life could
be worth sustaining regardless of any favorability
classifications because it has intrinsic value to rela-




Accurate outcome prediction remains unavailable,
although it has huge consequences on decision-
making and it is crucial for patients, proxies and
physicians [18
&
,35,45,49,50]. Physicians are fre-
quently unable to make accurate predictions and
although prognostication may be consideredrved. www.co-criticalcare.com 3
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Copstraightforward at the extremes of the spectrum, it
remains difficult in the middle [29
&
,36,45]. This is
disturbing, as a physician’s perception on long-term
prognosis likely influences treatment decisions.
The long-term physical, cognitive, emotional and
behavioral outcome after TBI is determined by
injury characteristics as well as by contextual factors
of the patient and the caregiver. Such issues are not
covered in the CRASH and IMPACT prognostic mod-
els that focus on mortality and severe disability at
6 months’ post injury. Although helpful in estimat-
ing survival, these models do not cover outcomes,
such as independence in daily living and ultimately





The reasons for failure of prediction are: the
heterogeneous nature of s-TBI and concurring
comorbidities and their unknown effect on outcome
[50,55,56
&
,57]; unclear/incomplete clinical infor-
mation, including a patient’s neurological state or
level of consciousness [58,59]; largely unknown
pathophysiological mechanisms of brain injury







]; prediction models do not include long-term
(health-related) QOL, although long-term outcome
changes have been reported and patients/proxies





models are based on large retrospective data sets




Balancing between beneficence and nonmalefi-
cence in clinical decision-making after s-TBI is a
process of weighing the chance between favorable
and nonfavorable outcome based on clinical exper-
tise and subjective evaluations with ill-defined clin-
ical endpoints [45]. Yet, it is considered common
sense that lifesaving interventions should be with-
held when the predicted risk of ‘unfavorable’ out-
come is high, whereas depriving a patient of a
possible favorable outcome can be seen as inappro-
priate care. The approach to treat all patients with
the potential to survive inherently includes the risk
of survival with an unacceptable outcome. All physi-
cians should appreciate and communicate the exist-
ing multidimensional uncertainty, and decisions
should not be guided by assumptions that falsely





The risk of selection bias and self-fulfilling
prophecies should be noted. Assumptions on poor
prognosis that lead to treatment-limiting decisions
and probably contribute to a worse outcome and





In clinical care the estimated prognosis is based on
clinical characteristics, subjective evaluation of the4 www.co-criticalcare.com
yright © 2019 Wolters Kluwer Health, Inc. Unauthclinician and contextual information at a short
interval post onset. However, prognosis after s-TBI
is dynamic in which the passage of time changes
the predicted probability of a favorable outcome
[71
&
,72]. In case of prognostic uncertainty and a
small chance of ‘acceptable’ outcome, full critical
care treatment should be initiated and continued to
allow for best possible recovery. Information on
clinical progress, neurological recovery, the
patient’s treatment and outcome preferences (when
necessary through proxies), and multidisciplinary
discussion (ideally with moral council) need to be
included in decision-making – and this information
only becomes available with time.
Striving for personalized care is promising and
allows for appreciation of the general injury applied
in an individualized context [73]. In the subacute
phase, frequent re-evaluation and communication
are essential; when treatment has become dispropor-
tionate, given the outcome, withdrawal of life-
sustaining measures can be considered even at later
moments in time. Despite the associated increased
healthcare consumption and costs, the survival of
patients with severe disabilities and the longer period
of suffering for patients/proxies can be legitimized if
more patients survive with acceptable outcome.PATIENT, PROXY OR SHARED DECISION-
MAKING
Values, preferences and treatment wishes of patients
(when necessary obtained through proxies) are to be
respected and should be incorporated in clinical
decision-making. Patient with s-TBI are incapable
to decide, and their preferences have rarely been





]. Proxies are then con-
fronted with difficult treatment dilemmas, but
information as desired by proxies is not always
provided and a patients’ social circumstances and








Proxies are mostly unprepared, confused by
uncertainty and hope, and unequipped to fully
understand the uncertainties of prognostication
and clinical decision-making [7,75].
This puts a high burden on the clinician’s should-
ers. Although medical paternalism is increasingly
replaced by ‘shared decision-making’, the latter
remains a difficult, if not impossible proposition when





conversations with proxies, it is recommended to
provide early, frequent, understandable, honest, and
consistent multidisciplinary communication aboutVolume 25  Number 00  Month 2019
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the patient’s condition, consequences of actions, and
prognosis, while acknowledging an acceptable level of
uncertainty. Although specific needs are highly vari-
ableasperceptionsaredifferentandoften inconsistent
with reality, physicians must align unrealistic expec-
tations with medical reality; in case of conflicts, moral
deliberation could be helpful and otherwise profes-
sional judgement should prevail.CONSIDERATIONS FROM A SOCIETAL
PERSPECTIVE
‘The rule of rescue’ is a powerful ethical proclivity
ingrained in human nature, possible even more in
acute care physicians, to rescue those in immediate
danger, regardless of risks or costs [77]. ‘Performing
against the odds’ heroism is often in conflict with
the utilitarian approach, which aims at the overall
performance of the entire healthcare system instead
of the entire focus being on the benefits of a
single individual.
In this context, it is considered difficult to justify
lifesaving neurosurgical interventions resulting in
unacceptable outcome at enormous healthcare
costs. The ethical question transcends from individ-
ual values to societal and political valuation of life
related to costs. Studies assessing in-hospital costs
after s-TBI, however, suggest rather an ‘acceptable’
degree of in-hospital treatment costs, although vari-
ation is high and study quality generally poor [2,78].
Studies on the long-term costs of patients after s-TBI
or patients with severe disorders of consciousness
are unfortunately scarce, prohibiting solid conclu-
sions. Admittedly, money that has been spent can-
not be used to treat other patients with possibly
more effective treatments. This perspective, how-
ever, should not be a prominent variable in arguing
for, or against early treatment-limiting decisions.
Depriving some patients of recovery to an accept-
able outcome should be absolutely minimized in
societal decision-making.
Nonetheless, theremust be apointwhereTBI is so
severe and patient outcome so unacceptable as to
justify the enormous associated healthcare costs.
Establishing this point is necessary because health-
care costs increase and healthcare budgets are
limited. Therefore, the cost-effectiveness of interven-
tions should be evaluated, and weighted to the maxi-
mum amount. Limitations on costs to maintain life
have already been set by politicians. For example,
the cut-off of cost-effective treatments in The
Netherlands is s80.000 per quality adjusted life year
[79]. The justification and number of this cut-off
should not be determined solely by politicians,
but also involve the contributions of experienced
physicians and other health-care professionals.1070-5295 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese
opyright © 2019 Wolters Kluwer Health, Inc. UnaA commonly perceived advantage of including
this economic perspective in decision-making is the
objectivity of the criterion to decide whether or not
to perform an intervention. We should, however,
not forget that focusing on cost–benefit analyses
fails to recognize individual aspects of care and the
social utility of caring for those most in need. People
obtain benefit from the belief that they live in a
compassionate and humane society where patients
in need will not be ignored merely on the basis
of costs.ACUTE AND CHRONIC CARE
Because of the chronic consequences of s-TBI, many
patients and proxies need adequate lifelong care to
optimize outcome [80,81]. Specialized rehabilita-





]. Caretakers and research-
ers of both subacute and chronic care should collab-
orate closely and become familiar with the needs,
challenges and possibilities along the entire chain
of care.
Regrettably, in some healthcare systems,
patients without enough progress of recovery dur-
ing rehabilitation are discharged to nursing homes
lacking proper rehabilitation or diagnostic over-
sight, depriving them of opportunities to recover
[75,85]. This seems unfair, as ‘normal’ recovery
processes of patients and their brains still remain
largely unknown, and subtle progress is known to be







]. Many novel rehabilita-
tion initiatives have been developed, and also





]. Until we really
know what is best, providing appropriate care is
something that we as a society morally owe to all
patients, while not discounting that catastrophic
conditions, such as unresponsive wakefulness syn-
drome or minimally conscious state are accompa-
nied by severe disabilities and enormous challenges
[41
&&
,89]. Although the gravity of the outcome
could be obscured by the gratitude of survival, many
will doubt this is a life worth living [75].FUTURE RESEARCH
Future research initiatives will focus on the effec-
tiveness of new diagnostic and treatment modalities
including short-term and long-term functional out-
come and health-related QOL, along the whole
chain of care [90,91]; the measurement of well being
and impact on proxies and society; establishing
values of dignified existence (i.e. with ex-patients,rved. www.co-criticalcare.com 5
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Copproxies, physicians); specialized education pro-
grams for professionals and patients/proxies on
the topic of s-TBI; improving the reliability of prog-
nostic models by machine learning [92
&
,93].
Although these initiatives seem promising, and
will likely improve TBI care when successful, we
should not underestimate the difficulties in con-
ducting traditional studies, such as not only the
variation between patients, injuries and healthcare
systems but also the variety and potential bound-
aries of ethics and culture. Randomization of
severely injured TBI patients, as one example, is
considered inappropriate by many physicians. Pro-
spective, large, multicentered, compared-effective-
ness research initiatives might provide necessary
evidence in the future [50].CONCLUSION
Decision-making in s-TBI is highly complicated
because of uncertainty regarding treatment cost-
effectiveness, prognostication and unacceptability
of outcome, which are caused by a lack of scientific
evidence and also by different societal and individ-
ual values. Physicians absolutely do not inten-
tionally deprive patients of a chance on achieving
an outcome they would have considered acceptable.
Research collaborations between medical specialties
and across the borders of traditional sciences of
medicine, sociology and philosophy might lead to
practical evidence, reduced uncertainty and
improved care and outcome for s-TBI patients.Acknowledgements
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